Global COVID-19 In-Vitro Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our latest research, the global COVID-19 In-Vitro Diagnostics market size will reach USD million in 2030, growing at a CAGR of % over the analysis period.

The COVID-19 In-Vitro Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Market segmentation
COVID-19 In-Vitro Diagnostics market is split by Type and by Application. For the period 2024-2030, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Rapid Diagnostic Test (RDT)
    Enzyme Linked Immunosorbent Assay (ELISA)
    Neutralization Assay

Market segment by Application, can be divided into
    Home
    Hospital
    Clinical

Market segment by players, this report covers
    Cellex
    Abbott
    Roche
    BioMedomics
    BD
    Henry Schein
    Safecare Bio-Tech
    Mayo Clinic Laboratories
    Chembio Diagnostics
    Mount Sinai Laboratory
    Ortho Clinical Diagnostics
    Zhejiang Orient Gene Biotech
    Innovita Biological Technology
    Guangzhou Wondfo Biotech
    Guangdong Hecin-Scientific
    Dynamiker Biotechnology (Tianjin)
    ADVAITE

Market segment by regions, regional analysis covers
    North America
    Europe
    Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
    South America
    Middle East & Africa

The content of the study subjects, includes a total of 8 chapters:
Chapter 1, to describe COVID-19 In-Vitro Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of COVID-19 In-Vitro Diagnostics, with recent developments and future plans
Chapter 3, the COVID-19 In-Vitro Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4, to break the market size data at the region level, with key companies in the key region and COVID-19 In-Vitro Diagnostics market forecast, by regions, with revenue, from 2024 to 2030.
Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2024 to 2030.
Chapter 7 and 8, to describe COVID-19 In-Vitro Diagnostics research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of COVID-19 In-Vitro Diagnostics
    1.2 Classification of COVID-19 In-Vitro Diagnostics by Type
        1.2.1 Overview: Global COVID-19 In-Vitro Diagnostics Market Size by Type: 2024 Versus 2030
        1.2.2 Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Type in 2030
        1.2.3 Rapid Diagnostic Test (RDT)
        1.2.4 Enzyme Linked Immunosorbent Assay (ELISA)
        1.2.5 Neutralization Assay
    1.3 Global COVID-19 In-Vitro Diagnostics Market by Application
        1.3.1 Overview: Global COVID-19 In-Vitro Diagnostics Market Size by Application: 2024 Versus 2030
        1.3.2 Home
        1.3.3 Hospital
        1.3.4 Clinical
    1.4 Global COVID-19 In-Vitro Diagnostics Market Size & Forecast
    1.5 Market Drivers, Restraints and Trends
        1.5.1 COVID-19 In-Vitro Diagnostics Market Drivers
        1.5.2 COVID-19 In-Vitro Diagnostics Market Restraints
        1.5.3 COVID-19 In-Vitro Diagnostics Trends Analysis

2 Company Profiles
    2.1 Cellex
        2.1.1 Cellex Details
        2.1.2 Cellex Major Business
        2.1.3 Cellex COVID-19 In-Vitro Diagnostics Product and Solutions
        2.1.4 Cellex Recent Developments and Future Plans
    2.2 Abbott
        2.2.1 Abbott Details
        2.2.2 Abbott Major Business
        2.2.3 Abbott COVID-19 In-Vitro Diagnostics Product and Solutions
        2.2.4 Abbott Recent Developments and Future Plans
    2.3 Roche
        2.3.1 Roche Details
        2.3.2 Roche Major Business
        2.3.3 Roche COVID-19 In-Vitro Diagnostics Product and Solutions
        2.3.4 Roche Recent Developments and Future Plans
    2.4 BioMedomics
        2.4.1 BioMedomics Details
        2.4.2 BioMedomics Major Business
        2.4.3 BioMedomics COVID-19 In-Vitro Diagnostics Product and Solutions
        2.4.4 BioMedomics Recent Developments and Future Plans
    2.5 BD
        2.5.1 BD Details
        2.5.2 BD Major Business
        2.5.3 BD COVID-19 In-Vitro Diagnostics Product and Solutions
        2.5.4 BD Recent Developments and Future Plans
    2.6 Henry Schein
        2.6.1 Henry Schein Details
        2.6.2 Henry Schein Major Business
        2.6.3 Henry Schein COVID-19 In-Vitro Diagnostics Product and Solutions
        2.6.4 Henry Schein Recent Developments and Future Plans
    2.7 Safecare Bio-Tech
        2.7.1 Safecare Bio-Tech Details
        2.7.2 Safecare Bio-Tech Major Business
        2.7.3 Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Product and Solutions
        2.7.4 Safecare Bio-Tech Recent Developments and Future Plans
    2.8 Mayo Clinic Laboratories
        2.8.1 Mayo Clinic Laboratories Details
        2.8.2 Mayo Clinic Laboratories Major Business
        2.8.3 Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Product and Solutions
        2.8.4 Mayo Clinic Laboratories Recent Developments and Future Plans
    2.9 Chembio Diagnostics
        2.9.1 Chembio Diagnostics Details
        2.9.2 Chembio Diagnostics Major Business
        2.9.3 Chembio Diagnostics COVID-19 In-Vitro Diagnostics Product and Solutions
        2.9.4 Chembio Diagnostics Recent Developments and Future Plans
    2.10 Mount Sinai Laboratory
        2.10.1 Mount Sinai Laboratory Details
        2.10.2 Mount Sinai Laboratory Major Business
        2.10.3 Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Product and Solutions
        2.10.4 Mount Sinai Laboratory Recent Developments and Future Plans
    2.11 Ortho Clinical Diagnostics
        2.11.1 Ortho Clinical Diagnostics Details
        2.11.2 Ortho Clinical Diagnostics Major Business
        2.11.3 Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Product and Solutions
        2.11.4 Ortho Clinical Diagnostics Recent Developments and Future Plans
    2.12 Zhejiang Orient Gene Biotech
        2.12.1 Zhejiang Orient Gene Biotech Details
        2.12.2 Zhejiang Orient Gene Biotech Major Business
        2.12.3 Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Product and Solutions
        2.12.4 Zhejiang Orient Gene Biotech Recent Developments and Future Plans
    2.13 Innovita Biological Technology
        2.13.1 Innovita Biological Technology Details
        2.13.2 Innovita Biological Technology Major Business
        2.13.3 Innovita Biological Technology COVID-19 In-Vitro Diagnostics Product and Solutions
        2.13.4 Innovita Biological Technology Recent Developments and Future Plans
    2.14 Guangzhou Wondfo Biotech
        2.14.1 Guangzhou Wondfo Biotech Details
        2.14.2 Guangzhou Wondfo Biotech Major Business
        2.14.3 Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Product and Solutions
        2.14.4 Guangzhou Wondfo Biotech Recent Developments and Future Plans
    2.15 Guangdong Hecin-Scientific
        2.15.1 Guangdong Hecin-Scientific Details
        2.15.2 Guangdong Hecin-Scientific Major Business
        2.15.3 Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Product and Solutions
        2.15.4 Guangdong Hecin-Scientific Recent Developments and Future Plans
    2.16 Dynamiker Biotechnology (Tianjin)
        2.16.1 Dynamiker Biotechnology (Tianjin) Details
        2.16.2 Dynamiker Biotechnology (Tianjin) Major Business
        2.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Product and Solutions
        2.16.4 Dynamiker Biotechnology (Tianjin) Recent Developments and Future Plans
    2.17 ADVAITE
        2.17.1 ADVAITE Details
        2.17.2 ADVAITE Major Business
        2.17.3 ADVAITE COVID-19 In-Vitro Diagnostics Product and Solutions
        2.17.4 ADVAITE Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global COVID-19 In-Vitro Diagnostics Revenue and Share by Players (2024 & 2030)
    3.2 COVID-19 In-Vitro Diagnostics Players Head Office, Products and Services Provided
    3.3 COVID-19 In-Vitro Diagnostics Mergers & Acquisitions
    3.4 COVID-19 In-Vitro Diagnostics New Entrants and Expansion Plans

4 Global COVID-19 In-Vitro Diagnostics Forecast by Region
    4.1 Global COVID-19 In-Vitro Diagnostics Market Size by Region: 2024 VS 2030
    4.2 Global COVID-19 In-Vitro Diagnostics Market Size by Region, (2024-2030)
    4.3 North America
        4.3.1 Key Companies of COVID-19 In-Vitro Diagnostics in North America
        4.3.2 Current Situation and Forecast of COVID-19 In-Vitro Diagnostics in North America
        4.3.3 North America COVID-19 In-Vitro Diagnostics Market Size and Prospect (2024-2030)
    4.4 Europe
        4.4.1 Key Companies of COVID-19 In-Vitro Diagnostics in Europe
        4.4.2 Current Situation and Forecast of COVID-19 In-Vitro Diagnostics in Europe
        4.4.3 Europe COVID-19 In-Vitro Diagnostics Market Size and Prospect (2024-2030)
    4.5 Asia-Pacific
        4.5.1 Key Companies of COVID-19 In-Vitro Diagnostics in Asia-Pacific
        4.5.2 Current Situation and Forecast of COVID-19 In-Vitro Diagnostics in Asia-Pacific
        4.5.3 Asia-Pacific COVID-19 In-Vitro Diagnostics Market Size and Prospect (2024-2030)
        4.5.4 China
        4.5.5 Japan
        4.5.6 South Korea
    4.6 South America
        4.6.1 Key Companies of COVID-19 In-Vitro Diagnostics in South America
        4.6.2 Current Situation and Forecast of COVID-19 In-Vitro Diagnostics in South America
        4.6.3 South America COVID-19 In-Vitro Diagnostics Market Size and Prospect (2024-2030)
    4.7 Middle East & Africa
        4.7.1 Key Companies of COVID-19 In-Vitro Diagnostics in Middle East & Africa
        4.7.2 Current Situation and Forecast of COVID-19 In-Vitro Diagnostics in Middle East & Africa
        4.7.3 Middle East & Africa COVID-19 In-Vitro Diagnostics Market Size and Prospect (2024-2030)

5 Market Size Segment by Type
    5.1 Global COVID-19 In-Vitro Diagnostics Market Forecast by Type (2024-2030)
    5.2 Global COVID-19 In-Vitro Diagnostics Market Share Forecast by Type (2024-2030)

6 Market Size Segment by Application
    6.1 Global COVID-19 In-Vitro Diagnostics Market Forecast by Application (2024-2030)
    6.2 Global COVID-19 In-Vitro Diagnostics Market Share Forecast by Application (2024-2030)

7 Research Findings and Conclusion

8 Appendix
    8.1 Methodology
    8.2 Research Process and Data Source
    8.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global COVID-19 In-Vitro Diagnostics Revenue by Type, (USD Million), 2024 VS 2030
    Table 2. Global COVID-19 In-Vitro Diagnostics Revenue by Application, (USD Million), 2024 VS 2030
    Table 3. Cellex Corporate Information, Head Office, and Major Competitors
    Table 4. Cellex Major Business
    Table 5. Cellex COVID-19 In-Vitro Diagnostics Product and Solutions
    Table 6. Abbott Corporate Information, Head Office, and Major Competitors
    Table 7. Abbott Major Business
    Table 8. Abbott COVID-19 In-Vitro Diagnostics Product and Solutions
    Table 9. Roche Corporate Information, Head Office, and Major Competitors
    Table 10. Roche Major Business
    Table 11. Roche COVID-19 In-Vitro Diagnostics Product and Solutions
    Table 12. BioMedomics Corporate Information, Head Office, and Major Competitors
    Table 13. BioMedomics Major Business
    Table 14. BioMedomics COVID-19 In-Vitro Diagnostics Product and Solutions
    Table 15. BD Corporate Information, Head Office, and Major Competitors
    Table 16. BD Major Business
    Table 17. BD COVID-19 In-Vitro Diagnostics Product and Solutions
    Table 18. Henry Schein Corporate Information, Head Office, and Major Competitors
    Table 19. Henry Schein Major Business
    Table 20. Henry Schein COVID-19 In-Vitro Diagnostics Product and Solutions
    Table 21. Safecare Bio-Tech Corporate Information, Head Office, and Major Competitors
    Table 22. Safecare Bio-Tech Major Business
    Table 23. Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Product and Solutions
    Table 24. Mayo Clinic Laboratories Corporate Information, Head Office, and Major Competitors
    Table 25. Mayo Clinic Laboratories Major Business
    Table 26. Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Product and Solutions
    Table 27. Chembio Diagnostics Corporate Information, Head Office, and Major Competitors
    Table 28. Chembio Diagnostics Major Business
    Table 29. Chembio Diagnostics COVID-19 In-Vitro Diagnostics Product and Solutions
    Table 30. Mount Sinai Laboratory Corporate Information, Head Office, and Major Competitors
    Table 31. Mount Sinai Laboratory Major Business
    Table 32. Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Product and Solutions
    Table 33. Ortho Clinical Diagnostics Corporate Information, Head Office, and Major Competitors
    Table 34. Ortho Clinical Diagnostics Major Business
    Table 35. Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Product and Solutions
    Table 36. Zhejiang Orient Gene Biotech Corporate Information, Head Office, and Major Competitors
    Table 37. Zhejiang Orient Gene Biotech Major Business
    Table 38. Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Product and Solutions
    Table 39. Innovita Biological Technology Corporate Information, Head Office, and Major Competitors
    Table 40. Innovita Biological Technology Major Business
    Table 41. Innovita Biological Technology COVID-19 In-Vitro Diagnostics Product and Solutions
    Table 42. Guangzhou Wondfo Biotech Corporate Information, Head Office, and Major Competitors
    Table 43. Guangzhou Wondfo Biotech Major Business
    Table 44. Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Product and Solutions
    Table 45. Guangdong Hecin-Scientific Corporate Information, Head Office, and Major Competitors
    Table 46. Guangdong Hecin-Scientific Major Business
    Table 47. Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Product and Solutions
    Table 48. Dynamiker Biotechnology (Tianjin) Corporate Information, Head Office, and Major Competitors
    Table 49. Dynamiker Biotechnology (Tianjin) Major Business
    Table 50. Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Product and Solutions
    Table 51. ADVAITE Corporate Information, Head Office, and Major Competitors
    Table 52. ADVAITE Major Business
    Table 53. ADVAITE COVID-19 In-Vitro Diagnostics Product and Solutions
    Table 54. Global COVID-19 In-Vitro Diagnostics Revenue (USD Million) by Players (2024 & 2030)
    Table 55. Global COVID-19 In-Vitro Diagnostics Revenue Share by Players (2024 & 2030)
    Table 56. COVID-19 In-Vitro Diagnostics Players Head Office, Products and Services Provided
    Table 57. COVID-19 In-Vitro Diagnostics Mergers & Acquisitions in the Past Five Years
    Table 58. COVID-19 In-Vitro Diagnostics New Entrants and Expansion Plans
    Table 59. Global Market COVID-19 In-Vitro Diagnostics Revenue (USD Million) Comparison by Region (2024 VS 2030)
    Table 60. Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Region (2024-2030)
    Table 61. Key Companies of COVID-19 In-Vitro Diagnostics in North America
    Table 62. Current Situation and Forecast of COVID-19 In-Vitro Diagnostics in North America
    Table 63. Key Companies of COVID-19 In-Vitro Diagnostics in Europe
    Table 64. Current Situation and Forecast of COVID-19 In-Vitro Diagnostics in Europe
    Table 65. Key Companies of COVID-19 In-Vitro Diagnostics in Asia-Pacific
    Table 66. Current Situation and Forecast of COVID-19 In-Vitro Diagnostics in Asia-Pacific
    Table 67. Key Companies of COVID-19 In-Vitro Diagnostics in China
    Table 68. Key Companies of COVID-19 In-Vitro Diagnostics in Japan
    Table 69. Key Companies of COVID-19 In-Vitro Diagnostics in South Korea
    Table 70. Key Companies of COVID-19 In-Vitro Diagnostics in South America
    Table 71. Current Situation and Forecast of COVID-19 In-Vitro Diagnostics in South America
    Table 72. Key Companies of COVID-19 In-Vitro Diagnostics in Middle East & Africa
    Table 73. Current Situation and Forecast of COVID-19 In-Vitro Diagnostics in Middle East & Africa
    Table 74. Global COVID-19 In-Vitro Diagnostics Revenue Forecast by Type (2024-2030)
    Table 75. Global COVID-19 In-Vitro Diagnostics Revenue Forecast by Application (2024-2030)
List of Figures
    Figure 1. COVID-19 In-Vitro Diagnostics Picture
    Figure 2. Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Type in 2030
    Figure 3. Rapid Diagnostic Test (RDT)
    Figure 4. Enzyme Linked Immunosorbent Assay (ELISA)
    Figure 5. Neutralization Assay
    Figure 6. COVID-19 In-Vitro Diagnostics Revenue Market Share by Application in 2030
    Figure 7. Home Picture
    Figure 8. Hospital Picture
    Figure 9. Clinical Picture
    Figure 10. Global COVID-19 In-Vitro Diagnostics Market Size, (USD Million): 2024 VS 2030
    Figure 11. Global COVID-19 In-Vitro Diagnostics Revenue and Forecast (2024-2030) & (USD Million)
    Figure 12. COVID-19 In-Vitro Diagnostics Market Drivers
    Figure 13. COVID-19 In-Vitro Diagnostics Market Restraints
    Figure 14. COVID-19 In-Vitro Diagnostics Market Trends
    Figure 15. Cellex Recent Developments and Future Plans
    Figure 16. Abbott Recent Developments and Future Plans
    Figure 17. Roche Recent Developments and Future Plans
    Figure 18. BioMedomics Recent Developments and Future Plans
    Figure 19. BD Recent Developments and Future Plans
    Figure 20. Henry Schein Recent Developments and Future Plans
    Figure 21. Safecare Bio-Tech Recent Developments and Future Plans
    Figure 22. Mayo Clinic Laboratories Recent Developments and Future Plans
    Figure 23. Chembio Diagnostics Recent Developments and Future Plans
    Figure 24. Mount Sinai Laboratory Recent Developments and Future Plans
    Figure 25. Ortho Clinical Diagnostics Recent Developments and Future Plans
    Figure 26. Zhejiang Orient Gene Biotech Recent Developments and Future Plans
    Figure 27. Innovita Biological Technology Recent Developments and Future Plans
    Figure 28. Guangzhou Wondfo Biotech Recent Developments and Future Plans
    Figure 29. Guangdong Hecin-Scientific Recent Developments and Future Plans
    Figure 30. Dynamiker Biotechnology (Tianjin) Recent Developments and Future Plans
    Figure 31. ADVAITE Recent Developments and Future Plans
    Figure 32. Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Region (2024-2030)
    Figure 33. Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Region in 2030
    Figure 34. North America COVID-19 In-Vitro Diagnostics Revenue (USD Million) and Growth Rate (2024-2030)
    Figure 35. Europe COVID-19 In-Vitro Diagnostics Revenue (USD Million) and Growth Rate (2024-2030)
    Figure 36. Asia-Pacific COVID-19 In-Vitro Diagnostics Revenue (USD Million) and Growth Rate (2024-2030)
    Figure 37. South America COVID-19 In-Vitro Diagnostics Revenue (USD Million) and Growth Rate (2024-2030)
    Figure 38. Middle East & Africa COVID-19 In-Vitro Diagnostics Revenue (USD Million) and Growth Rate (2024-2030)
    Figure 39. Global COVID-19 In-Vitro Diagnostics Market Share Forecast by Type (2024-2030)
    Figure 40. Global COVID-19 In-Vitro Diagnostics Market Share Forecast by Application (2024-2030)
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Companies Mentioned

Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE